A senior-led working model for consequential clinical development decisions — from first-in-human strategy through registrational readiness.
WHAT WE COVER
Indication, sequence, target product profile and development scenarios.
Population, comparator, endpoints, dose, expansion and evidence trade-offs.
Biomarkers, diagnostics, assay context, samples and data dependencies.
Cross-functional gaps, critical path, governance and 90-day ownership.
WAYS TO ENGAGE
An evidence-backed decision memo, risk map and 90-day action plan for one consequential clinical question.
Senior ownership of a clinical or cross-functional workstream without a full-time build.
A named team assembled to own a clinical deliverable end to end.
START WITH THE CONSTRAINT
Tell us the decision, deliverable or role you are working through. We will help identify the most useful next step.